E-MAIL: your-email@mail.com
E-MAIL: your-email@mail.com
GSK’s Hibsago is the first FDA-approved antisense oligonucleotide (ASO) for treating chronic hepatitis B.
imphoenix82
The approval marks the first global approval for bepirovirsen, and makes Hibsago the first and only treatment approved in Japan as a functional cure for chronic hepatitis B.
imphoenix82HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 9354115542
HealthXploreIndia @2026. All Rights Reserved.
